Læknaneminn - 01.04.1996, Síða 60

Þættir úr meingerð iktsýki
S, Anderson P, et al. Phenotypic abnormalides in CD8+
T lymphocyte subsets in patients with rheumatoid arthrit-
is. J Rheumatol 1991; 18: 1649-1654.
24. N.akao H, Eguchi K, Kawakami A, Migita K, Otsubi T,
ueki Y, Shimomura C, Tezuka H, Matsunanga M, Maeda
K, Nagataki S. Phenotypic characterization of lymphocyt-
es infiltrating synovial tissue from patients with rheuma-
toid arthritis : Analysis of lymphocytes isolated from
minced synovial tissue by dual immunofluorescent stain-
ing. J Rheumatol 1990; 17: 142-148.
25. Hanly JG, Pledger D, Parkhill W, Roberts M, Gross M.
Phenotypic characteristics of dissociated mononuclear
cells from rheumatoid synovial membranes. J Rheumatol
1990; 1274-1279.
26. Arinbjarnarson S, Jónsson T, Steinsson K, Jónsson H,
Geirsson ÁJ, Thorsteinsson J, Valdimarsson H. IgA
rheumatoid factor correlates with changes in B- and T-
lymphocyte subsets and disease manifestations in rheuma-
toid arthritis. J Rheumatol (samþykkt til birtingar).
27. Kim P-H, Kagnoff ME Transforming growth factor-1
increases IgA isotype switching at the clonal level. J
Immunol 1990; 145: 3773-3778.
28. Oursler MJ. Osteoclast synthesis and secretion and acti-
vation of latentTGF-. J Bone Min Res 1994; 9: 443-452.
29. Ulfgren AK, Linblad S, Klareskog L, Andersson J, Anders-
son U. Detection of cytokine producing cells in the
synovial membrane from patients with rheumatoid art-
hritis. Ann Rheum Dis 1995; 54: 654-661.
30. Boutard V, Havouis R, Fouqueray B, Philippe C, Moulin-
oux JP, Bud L. TGF- stimulates arginase activity in
macrophages. Implications for the regulation of macroph-
age cytotoxicity. J Immunol 1995;155:2077-2084.
31. Ishimi Y, Miyara C, Jin CH, Akatsu T, Abe E, Nakamura
Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T. IL-6 is
produced by osteoblasts and induces bone resorption. J
Immunoi 1990; 145: 3297-3303.
32. Brozik M, Rosztoczy I , Merety K, Balint G, Gaal M,
Balogh Z, et al. Interleukin-6 leveis in synovial fluids of
patients with different arthritides: correlation with local
IgM rheumatoid factor and systemic acute phase protein
production. J Rheumatol 1992; 19: 63-68.
33. Yokoyama A, Kohno N, Fujino S, Inoue Y, Hiwada K.
IgG and IgM rheumatoid factor levels paralell interleukin-
6 during the vasculitic phase in a patients with Churg-
Strauss syndrome. Intern Med 1995; 34: 646-648.
34. Rose NR, Bresler HS, Burek CL, Gleason SL, Kuppers
RC. Mapping the autoepitopes of thyroglobulin. Isr J
MedSci 1990; 26: 666-672.
35. del Guerco P. Regulatory structures on the V and C reg-
ions of immunoglobulin molecules. Immunol Today
1987; 8: 304-308.
36. Sinclair NR, Panoskaltis A. Immunoregulation by Fc sig-
nals: A mechanism for self-nonself discrimination.
Immunol Today 1987;8:76-79.
37. Levinson AI, Martin J. Rheumatoid factor: Dr. Jekyll or
Mr. Hyde. BrJRheumatol 1988;27:83-90.
38. Tighe H, Chen PP, Tucker R, Kipps, TJ, Roudier J, Jirik
FR, Carson DA. Function of B-cells expressing a human
IgM rheumatoid factor autoantibody in transgenic mice.
J Exp Med 1993; 177: 109-118.
39. Borretzen M, Randen I, Zdarsky E, Forre O, Natvig JB,
Thompson KM. Control of autoantibody affmity by sel-
ection against amino acid replacements in the complem-
entary determining regions. Proc Nat Acad Sci USA
1994; 26: 12917-12921.
40. Thompson KM, Randen I, Borretzen M, Forre O, Natvig
JB. Variable region gene usage of human rheumatoid fact-
ors derived from healthy donors following immunization.
Eur J Immunol 1994;24:1771-1778.
41. Thompson KM, Borretzen M, Natvig JB. New data on
rheumatoid factors in health and disease. Rheumatology
in Europe 1995; suppl. 2: 165-167.
LÆKNANEMIIMN
52
1. tbl. 1996, 49. árg.